The year saw the emergence of a new version of an old drug that proved beneficial in patients who have heart failure with ...

Review clinical classifications, diagnostic procedures, and management strategies for cardiomyopathy and heart failure in this comprehensive overview.

Receive the the latest news, research, and presentations from major meetings right to your inbox. TCTMD ® is produced by the Cardiovascular Research Foundation ® (CRF). CRF ® is committed to igniting ...

Cardiovascular disease remains a leading global cause of death, and we break down its pathology, risk factors, and the ...

Severe valvular heart disease was not uncommon among patients with cancer, and intervention to manage the valvular disease ...

The SGLT2 inhibitor medicines have changed how heart failure is managed. Originally sodium-glucose cotransporter 2 (SGLT2) inhibitors were used to lower blood sugar levels in people who have type 2 ...

The CHARM program consisted of 3 component trials, each comparing candesartan with placebo in a distinct population of patients with symptomatic heart failure [9]: CHARM-Alternative: patients with ...

Decompensated heart failure (DHF) means that symptoms from heart failure are severe enough to require immediate medical attention. Dyspnea or shortness of breath is the most common symptom of DHF.

Skill Checkup: Man With Obesity and Shortness of Breath A 79‐year‐old man with long-standing hypertension, dyslipidaemia and obesity presents with shortness of breath on exertion that began 6 months ...

A presentation about women and heart disease will be offered at 7 p.m. Wednesday, Oct. 6, at Curves in La Crescent, 309 N. Chestnut St. Topics that will be discussed include what a woman’s risk is for ...

Rheumatic heart disease is a serious complication of Group A Streptococcus infection. It can cause damage to the valves in your heart and may cause severe heart problems in the future. Rheumatic heart ...